Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Gross Profit (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Gross Profit for 12 consecutive years, with $419000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Profit fell 17.03% year-over-year to $419000.0, compared with a TTM value of $2.0 million through Sep 2025, down 14.7%, and an annual FY2024 reading of $2.1 million, down 8.68% over the prior year.
  • Gross Profit was $419000.0 for Q3 2025 at Arcadia Biosciences, down from $631000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $673000.0 in Q2 2024 and bottomed at -$3.9 million in Q4 2022.
  • Average Gross Profit over 5 years is $46947.4, with a median of $480000.0 recorded in 2023.
  • The sharpest move saw Gross Profit tumbled 1034.81% in 2022, then skyrocketed 328.57% in 2023.
  • Year by year, Gross Profit stood at $546000.0 in 2021, then crashed by 810.62% to -$3.9 million in 2022, then skyrocketed by 115.44% to $599000.0 in 2023, then tumbled by 35.23% to $388000.0 in 2024, then rose by 7.99% to $419000.0 in 2025.
  • Business Quant data shows Gross Profit for RKDA at $419000.0 in Q3 2025, $631000.0 in Q2 2025, and $518000.0 in Q1 2025.